Literature DB >> 2440248

Cyclic AMP-antagonist, a second messenger for insulin action, inhibits glucose-stimulated insulin secretion in isolated islets of Chinese hamsters.

H J Partke, H K Wasner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2440248     DOI： 10.1007/978-1-4684-5314-0_39

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  4 in total

1.  Biosynthesis of the endogenous cyclic adenosine monophosphate (AMP) antagonist, prostaglandylinositol cyclic phosphate (cyclic PIP), from prostaglandin E and activated inositol polyphosphate in rat liver plasma membranes.

Authors:  H K Wasner; M Lessmann; M Conrad; H Amini; E Psarakis; A Mir-Mohammad-Sadegh
Journal:  Acta Diabetol       Date:  1996-07       Impact factor: 4.280

2.  Prostaglandin E2 inhibits phosphoinositide metabolism in isolated pancreatic islets.

Authors:  S G Laychock
Journal:  Biochem J       Date:  1989-05-15       Impact factor: 3.857

3.  The endogenous cyclic AMP antagonist, cyclic PIP: its ubiquity, hormone-stimulated synthesis and identification as prostaglandylinositol cyclic phosphate.

Authors:  H K Wasner; U Salge; M Gebel
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

4.  Indomethacin treatment causes loss of insulin action in rats: involvement of prostaglandins in the mechanism of insulin action.

Authors:  H K Wasner; S Weber; H J Partke; H Amini-Hadi-Kiashar
Journal:  Acta Diabetol       Date:  1994-12       Impact factor: 4.280
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.